Published in Prostaglandins on January 01, 1977
Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest (1994) 2.55
Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest (1982) 1.57
Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension. J Clin Invest (2015) 1.51
Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest (1999) 1.30
Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest (2000) 1.05
Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest (1979) 1.00
Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin. Br J Pharmacol (1982) 0.93
Furosemide fails to alter plasma active or inactive renin in conscious sheep but does so in anaesthetized animals. J Physiol (1983) 0.82
Ions and signal transduction in the macula densa. J Clin Invest (2000) 0.80
Effect of tienoxolol, a new diuretic beta-blocking agent, on urinary prostaglandin excretion in the rat. Br J Pharmacol (1993) 0.75
Frusemide releases renin in the rat kidney when prostacyclin synthesis is suppressed. Br J Pharmacol (1984) 0.75
Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy. Diabetes (2016) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
Cloning of genomic DNA for human atrial natriuretic factor. Biochem Biophys Res Commun (1984) 6.53
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
The primary structure of epidermal growth factor. J Biol Chem (1972) 4.41
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension (1999) 3.33
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature (1995) 3.06
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50
Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int (2006) 2.44
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
The structure of ribonuclease-S at 3.5 A resolution. J Biol Chem (1967) 2.33
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation (2001) 2.14
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem (1998) 2.10
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest (1998) 1.90
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest (1989) 1.85
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (1991) 1.83
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem (1993) 1.81
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension (1997) 1.77
Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension (1991) 1.75
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest (1995) 1.72
Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res (1993) 1.69
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
Bradykinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells. J Biol Chem (1986) 1.65
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun (1989) 1.61
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A (1999) 1.60
Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem Biophys Res Commun (1984) 1.57
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
Design of a diffractometer and flow cell system for X-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease-S. J Mol Biol (1967) 1.56
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Significance of vascular renin for local generation of angiotensins. Hypertension (1991) 1.49
Isolation and characterization of renin-like enzymes from mouse submaxillary glands. Biochemistry (1972) 1.48
Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A (1999) 1.46
Atrial natriuretic factor and hypertension. A review and metaanalysis. Am J Hypertens (1991) 1.44
Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43
Hypertension and fibromuscular dysplasia of the renal arteries. Surgery (1969) 1.42
S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. Am J Physiol (1995) 1.40
Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther (1968) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem (2000) 1.38
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence. Nature (1984) 1.38
Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophys Res Commun (1992) 1.37
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol (1999) 1.37
Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins (1977) 1.36
Role of surface complexed iron in oxidant generation and lung inflammation induced by silicates. Am J Physiol (1992) 1.36
Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension (1993) 1.35
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med (1990) 1.35
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem (1982) 1.30
Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol (1992) 1.28
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol (1981) 1.28
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation (1987) 1.27
Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res (1999) 1.26
Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther (1970) 1.26
Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem (1982) 1.26
Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther (1977) 1.25
Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun (1989) 1.25
Amino acid sequence of mouse submaxillary gland renin. Proc Natl Acad Sci U S A (1982) 1.25
Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. N Engl J Med (1981) 1.24
The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res (2001) 1.24
Cigarette smoking and hemostatic function. Am Heart J (1988) 1.23
Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett (1992) 1.23
Formation of a novel dihydroxy acid from arachidonic acid by lipoxygenase-catalyzed double oxygenation in rat mononuclear cells and human leukocytes. J Biol Chem (1982) 1.22
Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int (1990) 1.22
Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest (1998) 1.21
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. J Clin Invest (1983) 1.21
Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg (1981) 1.21
Regulation of extracellular calcium entry in endothelial cells: role of intracellular calcium pool. Am J Physiol (1992) 1.21
Preparation and characterization of hydroperoxy-eicosatetraenoic acids (HPETEs). Prostaglandins (1980) 1.20
Mechanism of bradykinin-stimulated prostacyclin synthesis in porcine aortic endothelial cells. Biochim Biophys Acta (1982) 1.20
Operative management of renovascular hypertension. Results after a follow-up of fifteen to twenty-three years. J Vasc Surg (1984) 1.20
Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. J Immunol (1979) 1.20
Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int (1998) 1.19